Press Releases

• Optiq AI addresses demand for precision and high image quality in image-guided therapy. 
• Deep-learning-based noise reduction improves quality of live images. 
• New portfolio addresses wide range of clinical uses, operational needs, and financial considerations.

• The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification. 
• Certification reaffirms assay results are aligned with specialized mass spectrometry testing method. 
• The immunoassay test is a broadly available, economical option for patients and laboratories.

Collaborative agreement focuses on operational efficiencies, bringing new technology to the growing health system and Onvida Health’s commitment to building a healthier tomorrow

• Research assays help generate evidence about whether biomarkers can advance disease management
• Novel RUO tests can help scientists understand neurological function and disease progression
• Collaborative research is underway to translate scientific discovery into actionable evidence

• Animal Neurology Center in St. Louis installs helium-free 1.5T MR scanner for veterinary use
• Scanner also covers entire range of MR applications for general radiology

• Second-generation system combines anatomical and functional imaging in one scan
• Patient-oriented workflow for diagnosis and treatment of oncologic and neurological diseases
• AI-powered image reconstruction and simplified workflows for faster, easier operation

• First 70cm 1.5T MR platform with DryCool helium-free technology
• Artificial intelligence simplifies patient workflow, improves image quality, and accelerates exams
• Reduces annual energy consumption up to 56% compared with previous generation of MR scanners

• 93% of patients expect their doctor to order a test upon request
• 17% have requested a lab test they learned about from social media
• 27% have pursued a blood test, independent of a doctor’s recommendation

• Automated, AI-driven plaque analysis and PCI planning with coronary CT imaging
• Supports clinical decision-making by quantifying and qualifying plaque burden
• Adds to improvement of diagnostic and treatment paths, reducing unnecessary cath lab referrals

• Growing need for precision and high image quality in image-guided therapy
• AI-based live image denoising reduces noise for better image quality at the same dose
• Optiq AI will be available on three new imaging platforms

• Improved image reconstruction technique designed to support diagnostics in dense breast tissue
• Contrast-enhanced biopsy increases confidence without switching modalities
• Efficient solution enables long-term economic sustainability in radiology practices